1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Cerebral Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belayev, L; Busto, R; Ginsberg, MD; Watson, BD | 1 |
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Cerebral Infarction
| Article | Year |
|---|---|
Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Cerebral Infarction; Dronabinol; Male; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Time Factors | 1995 |